Detalhe da pesquisa
1.
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups.
Eur Urol Open Sci;
47: 65-72, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36601038
2.
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care.
Eur Urol;
80(4): 393-397, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34074559